wherein said administration provides for selective killing of {HEAD ~ cancer cells} by direct cytolysis and {TAIL ~ syncytia formation} in cells that are susceptible to replication of the fusogenic mutant HSV 2 
by
wherein said administration provides for selective killing of { HEAD ~ cancer cells } by direct cytolysis and { TAIL ~ syncytia formation } in cells that are susceptible to replication of the fusogenic mutant HSV 2
OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH